Growth Metrics

Catalyst Pharmaceuticals (CPRX) Operating Income Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 32.96%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -29.67%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -50.81%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 13.47%
7 Evaxion A 62.56 Bn 62.54 Bn - 16.35%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -12.10%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 55.96%
10 Catalyst Pharmaceuticals 3.82 Bn 3.07 Bn 134.92 Mn 27.17%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 27.17%
Dec 31, 2025 26.16%
Sep 30, 2025 38.21%
Jun 30, 2025 32.39%
Mar 31, 2025 53.95%
Dec 31, 2024 70.22%
Sep 30, 2024 53.76%
Jun 30, 2024 50.74%
Mar 31, 2024 40.40%
Dec 31, 2023 69.13%
Sep 30, 2023 -73.00%
Jun 30, 2023 65.61%
Mar 31, 2023 49.30%
Dec 31, 2022 56.69%
Sep 30, 2022 21.94%
Jun 30, 2022 37.63%
Mar 31, 2022 169.53%
Dec 31, 2021 41.92%
Sep 30, 2021 54.83%
Jun 30, 2021 65.09%
Mar 31, 2021 53.99%
Dec 31, 2020 52.74%
Sep 30, 2020 67.72%
Jun 30, 2020 64.59%
Mar 31, 2020 62.44%
Dec 31, 2019 56.81%
Sep 30, 2019 76.92%
Jun 30, 2019 62.31%
Mar 31, 2019 45.90%
Dec 31, 2018 -33.84%
Sep 30, 2018 -17.71%
Jun 30, 2018 -8.96%
Mar 31, 2018 -11.40%
Dec 31, 2017 -11.43%
Sep 30, 2017 -1.58%
Jun 30, 2017 -11.82%
Mar 31, 2017 -10.08%
Dec 31, 2016 -16.81%
Sep 30, 2016 -6.44%
Jun 30, 2016 -21.97%
Mar 31, 2016 -54.07%
Dec 31, 2015 -60.22%
Sep 30, 2015 -57.52%
Jun 30, 2015 -66.17%
Mar 31, 2015 -46.51%
Dec 31, 2014 -25.11%
Sep 30, 2014 -53.73%
Jun 30, 2014 -28.86%
Mar 31, 2014 -32.18%
Dec 31, 2013 -54.63%
Sep 30, 2013 -52.88%